US 10934332
Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment
granted A61KA61K38/00A61K38/08
Quick answer
US patent 10934332 (Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment) held by The Regents of the University of California expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/00, A61K38/08, A61K38/10, A61K38/16